[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100536229":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":32,"locations":42,"responsibleParty":59,"collaborators":61,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":11,"eligibilityCriteria":69,"healthyVolunteers":66,"sex":70,"minAge":11,"maxAge":11,"enrollmentInfo":71,"targetDuration":11,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":44,"whyStopped":11,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Arm","EXPERIMENTAL",null,[13],"Other: Letters about NF1 Care (Content Type 1)",{"label":15,"type":10,"description":11,"interventionNames":16},"Enhanced Usual Care Arm",[17],"Other: Letters about NF1 Care (Content Type 2)",[19,23],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"Letters about NF1 Care (Content Type 1)","Participants will receive two letters about NF1 care, one for themselves and one for their primary care clinician, to read in advance of the patient's annual wellness visit",[9],{"type":6,"name":24,"description":21,"armGroupLabels":25,"otherNames":11},"Letters about NF1 Care (Content Type 2)",[15],[27,30],{"name":28,"affiliation":5,"role":29},"Vanessa Merker, PhD","PRINCIPAL_INVESTIGATOR",{"name":31,"affiliation":5,"role":29},"Scott Plotkin, MD, PhD",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":11,"email":37},"Paulina Arias Hernandez, MSW","CONTACT","6177245321","pahernandez@mgb.org",{"name":39,"role":35,"phone":40,"phoneExt":11,"email":41},"Evan Koch, BA","6177249574","eokoch@mgh.harvard.edu",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Boston","Massachusetts","02114","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-71.05977,42.35843,{"lat":54,"lon":53},[57],{"name":34,"role":35,"phone":58,"phoneExt":11,"email":37},"617-724-5321",{"type":29,"investigatorFullName":28,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Assistant Investigator",[62],{"name":63,"class":6},"Patient-Centered Outcomes Research Institute","100536229","a-decentralized-clinical-trial-to-promote-evidence-based-care-for-underserved-patients-with-neurofibromatosis-1-100536229",false,"NCT06262113","A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1","Adult Inclusion Criteria:\n\n* Currently lives in the United States (including Puerto Rico and other United States territories)\n* Has a clinical diagnosis of neurofibromatosis 1\n* Does not attend an NF clinic within the Children's Tumor Foundation NF Clinic Network\n* Has an in-person, well-person visit with a primary care provider scheduled within 3 months of their consent\n* Speaks English or Spanish\n\nParent\u002FGuardian of a Child with NF1 Inclusion Criteria:\n\n* Currently lives in the United States (including Puerto Rico and other United States territories)\n* Cares for a child (age \\\u003C18 years) with a clinical diagnosis of neurofibromatosis 1\n* Does not attend an NF clinic within the Children's Tumor Foundation NF Clinic Network\n* Their child has an in-person, well-person visit with a primary care provider scheduled within 3 months of their consent\n* Speaks English or Spanish\n\nExclusion Criteria:\n\n* Only one person per household may participate in the study\n* Unwilling or unable to give informed consent","ALL",{"count":72,"type":73},294,"ESTIMATED","INTERVENTIONAL",[76],"NA","The goal of this fully decentralized, randomized controlled trial is to compare the efficacy of two educational interventions for individuals with Neurofibromatosis 1 (NF1). The primary objective of the study is to determine which intervention leads to higher rates of evidenced-based health screenings for NF1 patients in primary care settings.\n\nAdults with NF1 and parents\u002Fguardians of children with NF1 from across the U.S. who do not go to a specialized NF clinic and who have an upcoming annual wellness visits (e.g. an annual physical, a well-child visit, etc.) scheduled with a primary care provider (PCP) are eligible to enroll in the study. To see if you might be eligible, fill out a prescreening survey here: https:\u002F\u002Fredcap.link\u002Fmynfguide",[79],"Neurofibromatosis 1",[81,82,83,84,85,86,87,88,89,90,91],"Neurofibromatosis","NF1","Guideline","Healthcare","PCP","Parent","Pediatric","Primary Care","Annual Care","Physical Exam","Well-Child","2025-09-30",{"date":94,"type":95},"2025-10-03","ACTUAL",{"date":97,"type":95},"2024-12-03",{"date":99,"type":73},"2026-08",{"name":5,"class":6},1]